Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses.

Weiland T, Lampe J, Essmann F, Venturelli S, Berger A, Bossow S, Berchtold S, Schulze-Osthoff K, Lauer UM, Bitzer M.

Int J Cancer. 2014 Jan 1;134(1):235-43. doi: 10.1002/ijc.28350. Epub 2013 Aug 7.

2.

Attenuated oncolytic measles virus strains as cancer therapeutics.

Msaouel P, Iankov ID, Dispenzieri A, Galanis E.

Curr Pharm Biotechnol. 2012 Jul;13(9):1732-41. Review.

3.

Primary resistance phenomena to oncolytic measles vaccine viruses.

Noll M, Berchtold S, Lampe J, Malek NP, Bitzer M, Lauer UM.

Int J Oncol. 2013 Jul;43(1):103-12. doi: 10.3892/ijo.2013.1914. Epub 2013 Apr 23.

PMID:
23612727
4.

Oncolytic viruses in the treatment of cancer: a review of current strategies.

Zeyaullah M, Patro M, Ahmad I, Ibraheem K, Sultan P, Nehal M, Ali A.

Pathol Oncol Res. 2012 Oct;18(4):771-81. Epub 2012 Jun 20. Review.

PMID:
22714538
5.

Potential and clinical translation of oncolytic measles viruses.

Robinson S, Galanis E.

Expert Opin Biol Ther. 2017 Mar;17(3):353-363. doi: 10.1080/14712598.2017.1288713. Review.

PMID:
28129716
6.

An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis.

Lampe J, Bossow S, Weiland T, Smirnow I, Lehmann R, Neubert W, Bitzer M, Lauer UM.

Gene Ther. 2013 Nov;20(11):1033-41. doi: 10.1038/gt.2013.28. Epub 2013 May 30.

PMID:
23719065
7.

[Measles virus: a future therapeutic agent in oncology?].

Touchefeu Y, Schick U, Harrington KJ.

Med Sci (Paris). 2012 Apr;28(4):388-94. doi: 10.1051/medsci/2012284016. Epub 2012 Apr 25. Review. French.

8.

Macrophage response to oncolytic paramyxoviruses potentiates virus-mediated tumor cell killing.

Tan DQ, Zhang L, Ohba K, Ye M, Ichiyama K, Yamamoto N.

Eur J Immunol. 2016 Apr;46(4):919-28. doi: 10.1002/eji.201545915. Epub 2016 Feb 3.

9.

Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus.

Ellerhoff TP, Berchtold S, Venturelli S, Burkard M, Smirnow I, Wulff T, Lauer UM.

Int J Oncol. 2016 Nov;49(5):1931-1944. doi: 10.3892/ijo.2016.3675. Epub 2016 Aug 31.

PMID:
27601235
10.

Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase.

Hartkopf AD, Bossow S, Lampe J, Zimmermann M, Taran FA, Wallwiener D, Fehm T, Bitzer M, Lauer UM.

Gynecol Oncol. 2013 Aug;130(2):362-8. doi: 10.1016/j.ygyno.2013.05.004. Epub 2013 May 12.

PMID:
23676551
11.

Measles virus as an oncolytic vector platform.

Blechacz B, Russell SJ.

Curr Gene Ther. 2008 Jun;8(3):162-75. Review.

PMID:
18537591
12.

A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.

Fujiyuki T, Yoneda M, Amagai Y, Obayashi K, Ikeda F, Shoji K, Murakami Y, Sato H, Kai C.

Oncotarget. 2015 Sep 22;6(28):24895-903. doi: 10.18632/oncotarget.4366.

13.

Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.

Hasegawa K, Pham L, O'Connor MK, Federspiel MJ, Russell SJ, Peng KW.

Clin Cancer Res. 2006 Mar 15;12(6):1868-75.

14.

Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo.

Künzi V, Oberholzer PA, Heinzerling L, Dummer R, Naim HY.

J Invest Dermatol. 2006 Nov;126(11):2525-32. Epub 2006 Sep 7.

15.

Questing for an optimal, universal viral agent for oncolytic virotherapy.

Paiva LR, Martins ML, Ferreira SC.

Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Oct;84(4 Pt 1):041918. Epub 2011 Oct 17.

PMID:
22181186
16.

Oncolytic measles virus strains as novel anticancer agents.

Msaouel P, Opyrchal M, Domingo Musibay E, Galanis E.

Expert Opin Biol Ther. 2013 Apr;13(4):483-502. doi: 10.1517/14712598.2013.749851. Epub 2013 Jan 6. Review.

17.

Potential of tumour cells for delivering oncolytic viruses.

Raykov Z, Rommelaere J.

Gene Ther. 2008 May;15(10):704-10. doi: 10.1038/gt.2008.34. Epub 2008 Mar 20. Review.

PMID:
18356816
18.

Oncolytic viruses in cancer therapy.

Vähä-Koskela MJ, Heikkilä JE, Hinkkanen AE.

Cancer Lett. 2007 Sep 8;254(2):178-216. Epub 2007 Mar 23. Review.

PMID:
17383089
19.

Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance.

Schirrmacher V.

Expert Opin Biol Ther. 2015;15(12):1757-71. doi: 10.1517/14712598.2015.1088000. Epub 2015 Oct 5. Review.

PMID:
26436571
20.

Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus.

Xia M, Meng G, Jiang A, Chen A, Dahlhaus M, Gonzalez P, Beltinger C, Wei J.

Oncotarget. 2014 Jun 15;5(11):3907-18.

Supplemental Content

Support Center